NCATSOvjeren akaunt

@ncats_nih_gov

Official Twitter account of NIH's National Center for Advancing Translational Sciences. Privacy Policy:

Bethesda, MD
Vrijeme pridruživanja: siječanj 2012.

Tweetovi

Blokirali ste korisnika/cu @ncats_nih_gov

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ncats_nih_gov

  1. Prikvačeni tweet
    14. sij

    Don’t miss this opportunity to network with patients, patient advocates, health care providers, researchers and others at on Friday, February 28, 2020. Together, we can share ideas and address the challenges that pose. Register today!

    , , i još njih 7
    Poništi
  2. Repurposing existing drugs for new uses has great potential for treating the many diseases still without a cure. Christine Colvis, Ph.D., director of the drug development partnerships programs, shares how NCATS is shaking up the research pipeline:

    Poništi
  3. 3. velj

    Network with patients, patient advocates, health care providers, researchers, industry partners and others at this year’s . Together, we can share information and work to address the challenges that pose. Register today!

    Poništi
  4. 3. velj
    Poništi
  5. proslijedio/la je Tweet
    2. velj
    Poništi
  6. 31. sij

    There's still time to register for at NIH? ⏰ Join NCATS and to hear about the latest collaborative research for :

    Poništi
  7. 30. sij

    If you are attending the for Pain, don’t miss the director of NCATS’ Stem Cell Translation Laboratory, Dr. Singec! He will be at the Workshop on New Resources for Therapeutic Discovery in the Grays Peak room at 2:30 p.m. MST on 2/3/20.

    Poništi
  8. 30. sij

    : Tao Deng, Ph.D., is a research scientist currently working on disease modeling and therapeutic strategies for fighting the and addressing pain-related diseases. Learn more about his background:

    Poništi
  9. proslijedio/la je Tweet
    29. sij

    Thank you to all the partners, panelists and speakers who contributed to the Workshop on Expanding AAV Manufacturing Capacity for Rare Disease Gene Therapies!

    Poništi
  10. 29. sij

    Join us for at on February 28! This year’s event will feature discussions on personalized medicine, shortening the diagnostic odyssey, improving access to and more! Learn more about the event:

    Poništi
  11. 29. sij

    Reminder: Join us for a webinar with TODAY at 1pm ET to get essential IP advice for commercialization. Register:

    Poništi
  12. 29. sij

    Day 2 of The Workshop on Expanding AAV Manufacturing Capacity for RD Gene Therapies is happening now. Tune into the Videocast is now:

    Poništi
  13. proslijedio/la je Tweet

    We're hosting a virtual workshop on for and on 02/19. Learn more and register:

    Poništi
  14. 28. sij

    On Monday, NCATS’ Sam Michael accompanied Aviv Elor, a Ph.D. student from & previous undergrad researcher with NCATS, who presented on exploring how mixed reality systems could be used to help researchers interact with microscopic data at . Congrats, Aviv!

    Sam Michael and Aviv Elor at SLAS 2020
    Poništi
  15. 28. sij

    Workshop on Expanding AAV Manufacturing Capacity for RD Gene Therapies (Day 1) - the Videocast is now available:

    Prikaži ovu nit
    Poništi
  16. 28. sij

    more than 7,000 have been identified, but approved drugs are available for only 500? Find out how the NCATS Pharmaceutical Collection can help scientists discover potential new uses for existing drugs:

    Poništi
  17. 28. sij

    Do you need help getting your research ideas patented? Join us for a webinar on protection with & Wed., Jan. 29, at 1 pm ET and learn how programs can advance your innovation. Register:

    Poništi
  18. 28. sij

    The Expanding AAV Manufacturing Capacity for Gene Therapies Workshop begins today! Attendees will explore— ✅ Logistical bottlenecks ✅ Master file best practices & opportunities ✅ Analytics & lot release testing Stay tuned to the videocast!

    Prikaži ovu nit
    Poništi
  19. 27. sij

    Kick off the new year with our first newsletter of 2020! 🥳 Get the latest in news, find out how researchers are working to advance telehealth, and more!

    Poništi
  20. 27. sij

    As at NIH approaches, NCATS Director Chris Austin, M.D., shares his encounter w/an end-stage ALS patient, over 30 yrs ago—“I have come to realize that , while intensely personal, are also an urgent issue.”

    Poništi
  21. 27. sij

    Attending this year’s Summit in Washington, D.C.? Don’t miss NCATS Director Dr. Christopher Austin’s keynote address on clinical discovery through treatment of wider ranges of patients at 1:15 p.m. ET tomorrow! View the agenda:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·